Nu Skin Enterprises Given Buy Rating at Deutsche Bank (NUS)
Nu Skin Enterprises (NYSE:NUS)‘s stock had its “buy” rating reaffirmed by Deutsche Bank in a research note issued on Thursday. They currently have a $70.00 price objective on the stock, down from their previous price objective of $110.00. Deutsche Bank’s price objective suggests a potential upside of 50.47% from the company’s current price.
Shares of Nu Skin Enterprises (NYSE:NUS) traded up 2.88% during mid-day trading on Thursday, hitting $47.86. 3,128,068 shares of the company’s stock traded hands. Nu Skin Enterprises has a 1-year low of $43.50 and a 1-year high of $140.50. The stock has a 50-day moving average of $67.02 and a 200-day moving average of $76.02. The company has a market cap of $2.821 billion and a P/E ratio of 7.65. Nu Skin Enterprises also was the target of unusually large options trading activity on Tuesday. Traders purchased 2,026 call options on the stock. This is an increase of 145% compared to the average daily volume of 828 call options.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $1.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.27 by $0.14. The company had revenue of $650.00 million for the quarter, compared to the consensus estimate of $709.03 million. During the same quarter in the previous year, the company posted $1.22 earnings per share. The company’s revenue for the quarter was down 3.1% on a year-over-year basis. Analysts expect that Nu Skin Enterprises will post $5.02 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity cut their price target on shares of Nu Skin Enterprises from $92.00 to $53.00 in a research note on Thursday. They now have a “hold” rating on the stock. Separately, analysts at JPMorgan Chase & Co. downgraded shares of Nu Skin Enterprises from an “overweight” rating to a “neutral” rating in a research note on Thursday. They now have a $50.00 price target on the stock, down previously from $100.00. Finally, analysts at Zacks downgraded shares of Nu Skin Enterprises from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 29th. They now have a $60.20 price target on the stock. Three research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company’s stock. Nu Skin Enterprises currently has an average rating of “Hold” and an average target price of $76.78.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.